T1	Entity 126 151	Maple Syrup Urine Disease
T2	KeyEntity 153 157	MSUD
T3	Entity 204 256	deficiency of branched-chain keto acid dehydrogenase
T4	KeyEntity 258 262	MSUD
T5	Entity 322 339	enzyme deficiency
R1	other_relation Arg1:T2 Arg2:T1	
#1	AnnotatorNotes R1	equivalent
R2	is_part_of Arg1:T3 Arg2:T2	
R3	is_part_of Arg1:T5 Arg2:T4	
T6	Entity 662 692	lacked a functional E2 subunit
T7	Entity 701 739	branched-chain keto acid dehydrogenase
T8	KeyEntity 568 572	MSUD
R4	participates_in Arg1:T8 Arg2:T6	
R5	is_part_of Arg1:T6 Arg2:T7	
T9	Entity 831 844	human E2 cDNA
T10	Entity 996 1011	E2 subunit gene
T11	Entity 1015 1053	branched-chain keto acid dehydrogenase
T12	KeyEntity 1105 1109	MSUD
T13	Entity 1246 1284	circulating branched-chain amino acids
T14	Entity 1196 1215	E2 immunoreactivity
T15	Entity 1147 1185	branched-chain keto acid dehydrogenase
T16	Entity 1327 1345	neonatal lethality
T17	Entity 1606 1651	circulating branched-chain amino acids levels
T18	Entity 1467 1514	Branched-chain keto acid dehydrogenase activity
T19	Entity 1519 1533	5â€“6% of normal
R6	is_part_of Arg1:T10 Arg2:T11	
T20	Entity 1115 1139	homozygous knockout mice
R7	is_part_of Arg1:T15 Arg2:T20	
R8	is_part_of Arg1:T14 Arg2:T20	
R9	is_part_of Arg1:T13 Arg2:T20	
R10	participates_in Arg1:T18 Arg2:T17	
#2	AnnotatorNotes R10	negative
T21	Entity 2002 2024	therapeutic strategies
T22	Entity 2034 2061	gene and cellular therapies
T23	Entity 2077 2106	devastating metabolic disease
T24	KeyEntity 1964 1968	MSUD
R11	is_part_of Arg1:T24 Arg2:T23	
